Exascale Labs completes $500M SPAC merger
At closing, Exascale issued 33,689,050 Class A and 30,645,739 Class B shares and redeemed 26,865,211 BCAR Class A for cash.
Exascale Labs Holdings Inc. (XLAB) reports completion of its business combination with SPAC D. Boral ARC Acquisition I Corp., redomiciling to Delaware and adopting the name Exascale Labs Holdings Inc. Exascale, a next-generation AI infrastructure provider focused on GPU-as-a-Service and related data-center solutions, becomes the operating business.
On August 27, 2026, Exascale issued or reserved an aggregate 33,689,050 Class A and 30,645,739 Class B Super Common shares as part of the transaction, including 50,000,000 shares as merger consideration valued at $500,000,000 ($10.00 per share). Holders of 26,865,211 BCAR Class A shares redeemed for cash. As of closing, there were 64,334,789 common shares outstanding and 14,099,992 warrants exercisable at $11.50 per share.
The dual-class structure gives Class B 20 votes per share; former Exascale holders own all Class B and the five-person board, with Hoansoo Lee as CEO and interim CFO. An equity incentive plan initially reserves 10,000,000 Class A shares with a 5% annual evergreen. Pro forma combined net losses were $4.15 million for the year ended June 30, 2025 and $3.47 million for the nine months ended March 31, 2026.
Positive
- None.
Negative
- None.
Filing Explained
Former Exascale holders control 94.8% of votes, while a six-month lock-up limits sales of their merger shares after the August 27 closing.
The completed combination leaves former Exascale holders with all
Lock-up agreements restrict sales or distributions of certain merger shares until the earlier of six months after the
The unaudited pro forma balance sheet as of
HTL International replaced Guangdong Prouden as independent auditor at closing; Guangdong Prouden’s prior report included an explanatory paragraph relating to going concern but no adverse opinion, disclaimer or reportable event.
The pro forma adjustments are based on available information and may change as further analysis is performed, with differences potentially material.
8-K Event Classification
Key Figures
Key Terms
Business Combination financial
Domestication Merger financial
Acquisition Merger financial
Simple Agreement for Future Equity financial
reverse recapitalization financial
GPU as a Service technical
FAQ
What does Exascale Labs Holdings Inc. (XLAB) disclose in this 8-K?
How many Exascale Labs (XLAB) shares are outstanding after the business combination?
What was the merger consideration paid to Exascale securityholders in the XLAB transaction?
How many BCAR shares were redeemed in the Exascale Labs (XLAB) de-SPAC merger?
What is the voting control structure of Exascale Labs Holdings Inc. (XLAB)?
What warrants and equity incentives does Exascale Labs (XLAB) have outstanding?
What are the pro forma losses for Exascale Labs (XLAB) after the business combination?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in charter)
| 000-0000 |
||||
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Introductory Note
As previously disclosed, on January 11, 2026, D. Boral ARC Acquisition I Corp., a British Virgin Islands business company (“BCAR”) entered into an Agreement and Plan of Merger (the “Business Combination Agreement”), with D. Boral ARC Merger Corporation, a Delaware corporation and a wholly owned subsidiary of BCAR (“PubCo”), D. Boral Arc Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of BCAR (“Merger Sub”), and Exascale Labs Inc., a Delaware corporation (“Exascale”). Capitalized terms used herein but not defined herein shall have the meanings ascribed to them in the Proxy Statement/Prospectus (as defined below).
On August 27, 2026 (the “Closing Date”), the parties consummated the transactions contemplated by the Business Combination Agreement (the “Business Combination”), following their approval by the shareholders of BCAR at the extraordinary general meeting of the shareholders of BCAR held on July 29, 2026 (the “Extraordinary General Meeting”), as follows:
The Domestication Merger
Prior to the effective time of the Acquisition Merger (as defined below), and in connection with the Business Combination, BCAR continued out of the British Virgin Islands and into the State of Delaware and redomiciled as, and became a, Delaware corporation by merging with and into PubCo (the “Domestication Merger”), with PubCo continuing as the surviving corporation pursuant to the Business Companies Act, (Revised Edition 2020) as amended, of the British Virgin Islands and Section 388 and other applicable provisions of the General Corporation Law of the State of Delaware. Upon the Domestication Merger, PubCo changed its name from “D. Boral ARC Merger Corporation” to “Exascale Labs Holdings Inc.”
At the effective time of the Domestication Merger, (i) each outstanding BCAR Class A ordinary share, par value, $0.0001 per share (“BCAR Class A Ordinary Share”) and BCAR Class B ordinary share, par value, $0.0001 per share (“BCAR Class B Ordinary Share,” and together with the BCAR Class A Ordinary Share, the “BCAR Ordinary Shares”) (other than BCAR Ordinary Shares owned by BCAR as treasury shares or owned by a direct or indirect subsidiary of BCAR, BCAR Ordinary Shares held by BCAR shareholders who properly exercised their dissenter’s rights under applicable British Virgin Islands law, and BCAR Class A Ordinary Shares that were redeemed in connection with the BCAR shareholder vote to approve the Business Combination and related proposals at the Extraordinary General Meeting) was cancelled and automatically converted into one share of Class A common stock, par value $0.0001 per share, of PubCo (“PubCo Class A Ordinary Common Stock”) and (ii) each outstanding warrant of BCAR (a “BCAR Warrant”) was assumed by and became an outstanding warrant of PubCo (“PubCo Warrant”), exercisable for PubCo Class A Ordinary Common Stock on the same terms, with adjustments as provided in the Business Combination Agreement.
The Acquisition Merger
Following the Domestication Merger, Merger Sub merged with and into Exascale, with Exascale surviving as a wholly-owned subsidiary of PubCo (the “Acquisition Merger”).
At the closing of the Acquisition Merger:
| ● | Each issued and outstanding Simple Agreement for Future Equity (each, a “SAFE”), by and between Exascale and the holder thereof (each, a “SAFEholder”), was canceled and converted into the right to receive a number of shares of PubCo Class A Ordinary Common Stock based on the SAFE’s “implied ownership percentage” as determined under the terms of the applicable SAFE (such implied ownership percentage being, in general, the product of (i) the quotient obtained by dividing (x) the SAFE’s purchase amount by (y) the SAFE’s post-money valuation cap, multiplied by (ii) 100); |
1
| ● | That certain base camp agreement, dated May 9, 2023, between Exascale and an investor (the “Base Camp Investment Agreement”) was cancelled and converted into the right to receive a number of shares of PubCo Class A Ordinary Common Stock based on the “implied ownership percentage” attributable to the Base Camp Investment Agreement (such implied ownership percentage being a fixed percentage determined in accordance with the terms of the Base Camp Investment Agreement); |
| ● | Each outstanding exascale equity incentive award was cancelled and converted into the right to receive a number of shares of PubCo Class A Ordinary Common Stock based on the “implied ownership percentage” attributable to the applicable award (such implied ownership percentage having been determined based on Exascale’s fully diluted capitalization); |
| ● | Each issued and outstanding Exascale Class A common stock was cancelled and converted into the right to receive a number of shares of PubCo Class A Ordinary Common Stock based on the “implied ownership percentage” attributable to Exascale’s Class A common stock (such implied ownership percentage having been determined based on Exascale’s fully diluted capitalization); |
| ● | Each issued and outstanding Exascale Class B common stock was cancelled and converted into the right to receive a number of shares of PubCo Class B common stock, par value $0.0001 per share (“PubCo Class B Super Common Stock,” and together with the PubCo Class A Ordinary Common Stock, the “PubCo Common Stock”) based on the “implied ownership percentage” attributable to Exascale’s Class B common stock (such implied ownership percentage having been determined based on Exascale’s fully diluted capitalization); and |
| ● | Each share in Merger Sub issued and outstanding immediately prior to the effective time of the Acquisition Merger, automatically became an issued share of Exascale (with such shares becoming the only issued shares of Exascale immediately after the effective time of the Acquisition Merger). |
No fractional shares of PubCo Common Stock were issued in connection with the Business Combination.
In connection with the Extraordinary General Meeting and the Business Combination, holders of 26,865,211 BCAR Class A Ordinary Shares exercised their right to redeem their shares for cash.
On the Closing Date, PubCo issued, or reserved for issuance, a total aggregate of 33,689,050 shares of PubCo Class A Ordinary Common Stock and 30,645,739 shares of PubCo Class B Super Common Stock, of which an aggregate of 19,354,261 shares of PubCo Class A Ordinary Common Stock and 30,645,739 shares of PubCo Class B Super Common Stock were issued to the former Exascale securityholders in exchange for their equity interests in Exascale, representing an aggregate merger consideration of $500,000,000 based on a deemed value of $10.00 per share of PubCo Common Stock.
As of the Closing Date and following the completion of the Business Combination, PubCo had approximately 64,334,789 shares of PubCo Common Stock issued and outstanding, consisting of approximately 33,689,050 shares of PubCo Class A Ordinary Common Stock and 30,645,739 shares of PubCo Class B Super Common Stock, and no shares of PubCo preferred stock issued and outstanding. In addition, as of the Closing Date, PubCo had 14,099,992 PubCo Warrants issued and outstanding, each whole PubCo Warrant entitling the holder thereof to purchase one share of PubCo Class A Ordinary Common Stock at an exercise price of $11.50 per share.
2
Listing of Securities
Prior to the Closing Date, BCAR’s units (the “BCAR Units”), the BCAR Class A Ordinary Shares and the BCAR Warrants were listed on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “BCARU,” “BCAR” and “BCARW,” respectively. In connection with the Business Combination, all of the BCAR Units separated into their component parts and ceased trading on Nasdaq.
As of the open of trading on August 28, 2026, the PubCo Class A Ordinary Common Stock and PubCo Warrants began trading on Nasdaq under the symbols “XLAB” and XLABW,” respectively. The PubCo Class B Super Common Stock are not listed on Nasdaq or any other securities exchange and are not publicly traded.
The description of the Business Combination Agreement contained in this Current Report on Form 8-K does not purport to be complete and is qualified in its entirety by the text of the Business Combination Agreement, a copy of which is attached as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The Business Combination Agreement is also described in detail in the definitive proxy statement/prospectus for the Business Combination filed by BCAR with the Securities and Exchange Commission (the “Proxy Statement/Prospectus”).
Item 1.01 Entry into a Material Definitive Agreement.
The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference.
Lock-Up Agreements
In connection with the Business Combination, PubCo entered into lock-up agreements (the “Lock-Up Agreements”) with the former stockholders of Exascale and the former SAFEholders pursuant to which such former stockholders and former SAFEholders agreed, subject to certain customary exceptions, not to effect any sale or distribution of certain shares of PubCo Common Stock issued to them in the Business Combination during the period commencing on the Closing Date and ending on the earlier of (i) the date that is six months after the Closing Date and (ii) the date on which PubCo completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the stockholders of PubCo having the right to exchange their shares of PubCo Common Stock for cash, securities or other property.
The foregoing description of the Lock-Up Agreements is qualified in its entirety by reference to the full text of the agreement relating to the former stockholders of Exascale and the agreement relating to the former SAFEholders of Exascale, copies of the forms of which are attached as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
Indemnification Agreements
In connection with the Business Combination, on the Closing Date, PubCo entered into indemnification agreements (the “Indemnification Agreements”) with each of its directors and executive officers. Subject to certain exceptions, the Indemnification Agreements provide that PubCo will indemnify each of its directors and executive officers for certain expenses, which may include attorneys’ fees, judgments, fines and settlement amounts, incurred by a director or officer in any action or proceeding arising out of that person’s services as a director or officer of PubCo or of any other company or enterprise to which the person provides services at PubCo’s request.
The foregoing description of the Indemnification Agreements is qualified in its entirety by reference to the form of Indemnification Agreement, a copy of the form of which is attached as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.
3
Item 1.02 Termination of a Material Definitive Agreement.
The information set forth in the Introductory Note of this Current Report on Form 8-K and Item 1.01 is incorporated herein by reference.
On the Closing Date, in connection with the consummation of the Business Combination, the Investment Management Trust Agreement between BCAR and Odyssey Transfer and Trust Company and the Administrative Services Agreement between BCAR and MFH 1, LLC (the “Sponsor”) were terminated. The Administrative Services Agreement had provided for monthly payments of $20,000 to the Sponsor in return for the Sponsor providing (or causing to be provided) certain office space and administrative services to BCAR.
Item 2.01 Completion of Acquisition or Disposition of Assets.
The disclosures set forth in the Introductory Note of this Current Report on Form 8-K and in Item 1.01 are incorporated into this Item 2.01 by reference.
4
FORM 10 INFORMATION
Item 2.01(f) of Form 8-K states that if the predecessor registrant was a shell company, as BCAR was immediately before the consummation of the Business Combination, then the registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10. Accordingly, PubCo is providing below the information that would be included in the Form 10 if it were to file a Form 10. Please note that the information provided below relates to PubCo following the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise requires.
Through the Business Combination, PubCo succeeded to the business of Exascale. Certain historical information relating to PubCo contained or incorporated by reference in this section of this Current Report on Form 8-K reflects or are incorporated by reference to the historical business, operations and financial information of Exascale for periods prior to the Closing, as indicated by the context and the applicable disclosure.
Cautionary Note Regarding Forward-Looking Statements
This document and the information incorporated by reference herein include “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included in or incorporated by reference in this Current Report on Form 8-K, regarding PubCo’s future financial performance, as well as its strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of PubCo’s management are forward-looking statements. When used in this Current Report on Form 8-K, the words “anticipate”, “believe”, “can”, “continue”, “could”, “estimate”, “expect”, “forecast”, “intend”, “may”, “might”, “plan”, “possible”, “potential”, “predict”, “project”, “seek”, “should”, “strive”, “target”, “will”, “would,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on PubCo’s management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. PubCo cautions you that these forward-looking statements are subject to all of the risks and uncertainties incident to its business, most of which are difficult to predict and many of which are beyond the control of PubCo.
These forward-looking statements are based on information available as of the date of this Current Report on Form 8-K, and current expectations, forecasts and assumptions, and involve a number of risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing PubCo’s views as of any subsequent date, and PubCo does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
As a result of a number of known and unknown risks and uncertainties, PubCo’s actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:
| ● | PubCo’s limited operating history and history of losses, including the going concern qualification in PubCo’s audited financial statements; |
| ● | PubCo’s ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, and the ability of PubCo to grow and manage growth profitably; |
| ● | PubCo’s future capital needs and PubCo’s ability to obtain sufficient additional financing on acceptable terms or at all; |
5
| ● | risks relating to the uncertainty of the projected financial information with respect to PubCo; |
| ● | the ability to maintain the listing of the PubCo Class A Ordinary Common Stock on Nasdaq following the Closing Date; |
| ● | changes in the market in which PubCo competes, including with respect to its competitive landscape, technology evolution or changes in applicable laws or regulations; |
| ● | demand uncertainty for artificial intelligence (“AI”) compute services, including slower-than-anticipated adoption of large language models, changes in customer workload requirements, budget constraints, or shifts toward alternative architectures or in-house compute solutions; |
| ● | fluctuations in utilization rates of PubCo’s graphics processing unit (“GPU”) capacity, which could negatively affect revenues, margins, and operating leverage; |
| ● | technological risks, including the performance, scalability, reliability, and security of PubCo’s platform, as well as the pace of innovation in AI hardware and software that could render PubCo’s offerings less competitive; |
| ● | competitive pressures from hyperscalers, cloud service providers, vertically integrated AI infrastructure companies, and other GPU-as-a-Service providers with greater scale, resources, or pricing flexibility; |
| ● | the impact of macroeconomic events, such as inflation, recessions or depressions, and war or fears of war; |
| ● | changes in the vertical markets that PubCo targets; |
| ● | the impact of current or future government regulation and oversight, including the U.S. federal, state and local authorities; |
| ● | the ability to launch new services and products or to profitably expand into new markets; |
| ● | the ability to develop and maintain effective internal controls and procedures, correct or remediate the previously identified material weaknesses, or correct or remediate any future identified material weaknesses; |
| ● | increased costs associated with being a public company; |
| ● | the exposure to any liability, protracted and costly litigation or reputational damage relating to PubCo’s data security; |
| ● | PubCo’s controlled company status under Nasdaq rules; and |
| ● | other risks and uncertainties set forth in the Proxy Statement/Prospectus in the section titled “Risk Factors.” |
Business and Facilities
The information set forth in the section of the Proxy Statement/Prospectus entitled “Information About Exascale” beginning on page 216 is incorporated herein by reference.
6
Risk Factors
The risks associated with PubCo’s business and operations following the Closing Date are described in the Proxy Statement/Prospectus in the section entitled “Risk Factors” beginning on page 54, which is incorporated herein by reference.
Financial Information
Audited Financial Statements
The following historical audited financial statements and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus and filed as exhibits hereto:
| ● | Audited consolidated financial statements of BCAR as of December 31, 2025 and for the period from March 20, 2025 (inception) through December 31, 2025, audited by Guangdong Prouden CPAs GP. |
| ● | Audited financial statements of Exascale as of and for the years ended June 30, 2025 and 2024, audited by HTL International, LLC. |
The historical audited financial statements of BCAR and the related notes are included in the Proxy Statement/Prospectus beginning on page F-20 of the Proxy Statement/Prospectus and are incorporated by reference herein.
The historical audited financial statements of Exascale and the related notes are included in the Proxy Statement/Prospectus beginning on page F-61 of the Proxy Statement/Prospectus and are incorporated by reference herein.
Unaudited Interim Financial Statements
The unaudited interim consolidated financial statements of Exascale as of and for the three and nine months ended March 31, 2026 and March 31, 2025, are included in the Proxy Statement/Prospectus beginning on page F-87 of the Proxy Statement/Prospectus and are incorporated by reference herein.
The unaudited interim consolidated financial statements of BCAR as of and for the three months ended March 31, 2026, and as of and for the period from March 20, 2025 (inception) through March 31, 2025, are included in the Proxy Statement/Prospectus beginning on page F-42 of the Proxy Statement/Prospectus and are incorporated by reference herein.
Unaudited Pro Forma Condensed Combined Financial Information
The unaudited pro forma condensed combined financial information of BCAR and Exascale as of March 31, 2026, for the nine months ended March 31, 2026, and for the year ended June 30, 2025 is set forth in Exhibit 99.1 hereto and incorporated by reference herein.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis of Financial Condition and Results of Operations of Exascale is included in the Proxy Statement/Prospectus in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Exascale” beginning on page 231 of the Proxy Statement/Prospectus and is incorporated herein by reference.
Management’s Discussion and Analysis of Financial Condition and Results of Operations of BCAR is included in the Proxy Statement/Prospectus in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of BCAR” beginning on page 212 of the Proxy Statement/Prospectus and is incorporated herein by reference.
7
Security Ownership of Certain Beneficial Owners and Management
The following table sets forth information regarding the beneficial ownership of PubCo Common Stock as of the Closing Date by:
| ● | each person who is known to be the beneficial owner of more than 5% of the PubCo Common Stock; |
| ● | each executive officer and director of PubCo; and |
| ● | all executive officers and directors of PubCo as a group. |
Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options, rights and convertible securities that are currently exercisable or exercisable within 60 days.
The information set forth in the table below is based on 64,334,789 shares of PubCo Common Stock outstanding immediately following the Closing Date, consisting of 33,689,050 shares of PubCo Class A Ordinary Common Stock having one (1) vote per share and 30,645,739 shares of PubCo Class B Super Common Stock having twenty (20) votes per share.
| Name(1) | PubCo Class A Ordinary Common Stock Beneficially Owned |
Percent of PubCo Class A Ordinary Common Stock |
PubCo Class B Super Common Stock Beneficially Owned |
Percent of PubCo Class B Super Common Stock |
Percent of Voting Control(2) |
|||||||||||||||
| Directors, and Other Named Executive Officers | ||||||||||||||||||||
| Hoansoo Lee(3) | - | - | 5,000,000 | 16.3 | 15.5 | |||||||||||||||
| Wenying Jia(4) | - | - | 25,645,739 | 83.7 | 79.3 | |||||||||||||||
| David Card | - | - | - | - | - | |||||||||||||||
| Shachar Kariv | - | - | - | - | - | |||||||||||||||
| Jaeyoung Shin | - | - | - | - | - | |||||||||||||||
| All directors and executive officers as a group (5 persons) | - | - | 30,645,739 | 100.0 | 94.8 | |||||||||||||||
| 5% Stockholders other than Directors and Officers | ||||||||||||||||||||
| MFH 1, LLC(5) | 11,633,369 | 34.5 | - | - | 1.8 | |||||||||||||||
| (1) | Unless otherwise noted, the business address of each of the following is c/o Exascale Labs Holdings Inc., 820 Gessner Road, Suite 332, Houston, Texas 77024. |
| (2) | Based on an aggregate of 64,334,789 Common Stock (consisting of 33,689,050 Class A Ordinary Common Stock having one (1) vote per share and 30,645,739 Class B Super Common Stock having twenty (20) votes per share). The voting percentage is calculated based on such voting rights. |
8
| (3) | Consists of (i) 2,000,000 shares of Class B Super Common Stock directly held by HSL Capital Management LLC, (ii) 1,000,000 shares of Class B Super Common Stock directly held by the Jisu Paul Lee Non-Grantor Directed Trust, (iii) 1,000,000 shares of Class B Super Common Stock directly held by the Sophia Jisun Lee Non-Grantor Directed Trust and (iv) 1,000,000 shares of Class B Super Common Stock directly held by the Gabriel Jihwan Lee Non-Grantor Directed Trust. Hoansoo Lee is the sole member and manager of HSL Capital Management LLC and has sole voting and dispositive power with respect to the Class B Super Common Stock directly held by HSL Capital Management LLC. Hoansoo Lee is the settlor of, and serves as investment advisor to, each of the Jisu Paul Lee Non-Grantor Directed Trust, the Sophia Jisun Lee Non-Grantor Directed Trust, and the Gabriel Jihwan Lee Non-Grantor Directed Trust, and the beneficiaries of each of those trusts are the children of Hoansoo Lee. As such, Mr. Lee may be deemed to beneficially own the shares directly held by such trusts. Mr. Lee disclaims beneficial ownership of such shares directly held by such trusts except to the extent of his pecuniary interest therein, if any, and the inclusion of such shares in this table shall not be deemed an admission of beneficial ownership for any purpose. |
| (4) | Consists of shares of Class B Super Common Stock directly held by Zerowave Ltd. Ms. Jia is the sole member and manager of Zerowave Ltd and has sole voting and dispositive power with respect to the shares directly held by Zerowave Ltd. |
| (5) | John Darwin is the manager of MFH 1, LLC and, accordingly, Mr. Darwin has sole voting and investment discretion with respect to the shares held of record by MFH 1, LLC. Mr. Darwin disclaims any economic interest in the shares held by MFH 1, LLC, except to the extent of his pecuniary interest therein. The business address of MFH 1, LLC is 10 E. 53rd Street, Suite 3001, New York, NY 10022. |
Information about Directors and Executive Officers
| Name | Age | Position(s) Held | ||
| Hoansoo Lee | 42 | Chief Executive Officer, Interim Chief Financial Officer and Class III Director | ||
| Wenying Jia | 57 | Chairperson and Class II Director | ||
| David Card | 70 | Class II Director | ||
| Shachar Kariv | 55 | Class I Director | ||
| Jaeyoung Shin | 48 | Class I Director |
Resignations and Appointments
In connection with the closing of the Business Combination, the pre-existing officers and directors of BCAR resigned from their respective positions as officers and/or directors of BCAR, in each case effective as of the effective time of the Domestication Merger.
In connection with the closing of the Business Combination, the pre-existing officers and directors of PubCo resigned from their respective positions as officers and/or directors of PubCo, in each case effective as of the Closing Date.
Effective as of the Closing Date, Hoansoo Lee was appointed as Chief Executive Officer, Interim Chief Financial Officer and a member of the PubCo Board, Wenying Jia was appointed as the Chairperson, and a member of the PubCo Board, and each of David Card, Shachar Kariv and Jaeyoung Shin. was appointed as a member of the PubCo Board.
Information, including biographical information, with respect to PubCo’s directors and executive officers after the Closing is included in the Proxy Statement/Prospectus in the section titled “Executive Officers and Directors of Exascale and Executive Officers And Directors of PubCo” beginning on page 257 of the Proxy Statement/Prospectus, which is incorporated herein by reference.
Board Composition
PubCo’s business and affairs are managed under the direction of the board of directors of PubCo (the “PubCo Board”). The PubCo Board consists of five directors and is divided into three classes, designated Class I, Class II and Class III, with each class serving staggered three-year terms and one class standing for election at each annual meeting of stockholders. Shachar Kariv and Jaeyoung Shin are the current Class I directors, David Card and Wenying Jia are the current Class II directors, and Hoansoo Lee is the current Class III director. The current terms of Class I, II and III directors will expire at the annual meeting of stockholders to be held in 2027, 2028 and 2029, respectively. Wenying Jia is the current Chairperson of the PubCo Board.
9
Role of the Board in Risk Oversight
The PubCo Board has extensive involvement in the oversight of risk management related to PubCo and its business and accomplished this oversight through the regular reporting to the PubCo Board by the audit committee. The audit committee represents the PubCo Board by periodically reviewing PubCo’s accounting, reporting and financial practices, including the integrity of its financial statements, the surveillance of administrative and financial controls and its compliance with legal and regulatory requirements.
Director Independence
David Card, Shachar Kariv and Jaeyoung Shin are PubCo’s independent directors, as defined under the rules promulgated by Nasdaq. PubCo’s independent directors have regularly scheduled meetings at which only independent directors are present. Any affiliated transactions are required to be on terms that the PubCo Board believes are no less favorable to PubCo than could be obtained from independent parties. None of the independent directors has any relationship with PubCo besides their service on the PubCo Board.
Board Committees
The standing committees of the PubCo Board consist of an audit committee, a compensation committee and a nominating and corporate governance committee.
Audit Committee
The audit committee of the PubCo Board consists of David Card, Shachar Kariv and Jaeyoung Shin, each of whom meets the definition of “independent director” for purposes of serving on the audit committee under the Nasdaq rules and the independence standards under Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Jaeyoung Shin is the chairperson of the audit committee. The audit committee’s duties, which are specified in PubCo’s Audit Committee Charter, include, but are not limited to:
| ● | assisting board oversight of (i) the integrity of PubCo’s financial statements, (ii) PubCo’s compliance with legal and regulatory requirements, (iii) PubCo’s independent registered public accounting firm’s qualifications and independence, and (iv) the performance of PubCo’s internal audit function and independent registered public accounting firm; |
| ● | the appointment, compensation, retention, replacement and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by PubCo; |
| ● | pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by PubCo, and establishing pre-approval policies and procedures; reviewing and discussing with the independent registered public accounting firm all relationships the auditors have with PubCo in order to evaluate their continued independence; |
| ● | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; |
| ● | obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i) the independent registered public accounting firm’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
10
| ● | meeting to review and discuss PubCo’s annual audited financial statements and quarterly financial statements with PubCo’s management and the independent auditor, including reviewing PubCo’s specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; |
| ● | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the Securities and Exchange Commission (“SEC”) prior to PubCo entering into such transaction; and |
| ● | reviewing with management, the registered public accounting firm and PubCo’s legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding PubCo’s financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
The PubCo Board has determined that Jaeyoung Shin qualifies as an “audit committee financial expert,” as defined under the rules and regulations of Nasdaq and the SEC.
Corporate Governance and Nominating Committee
The corporate governance and nominating committee of the PubCo Board consists of David Card, Shachar Kariv and Jaeyoung Shin. David Card is the chairperson of the corporate governance and nominating committee. The corporate governance and nominating committee is responsible for overseeing the selection of persons to be nominated to serve on the PubCo Board. The corporate governance and nominating committee considers persons identified by its members, management, stockholders, investment bankers and others. The guidelines for selecting nominees, which are specified in PubCo’s Corporate Governance and Nominating Committee Charter, generally provide that persons to be nominated (i) should have demonstrated notable or significant achievements in business, education or public service, (ii) should possess the requisite intelligence, education and experience to make a significant contribution to the PubCo Board and bring a range of skills, diverse perspectives and backgrounds to its deliberations and (iii) should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the stockholders of PubCo. The corporate governance and nominating committee will consider a number of qualifications relating to management and leadership experience, background and integrity and professionalism in evaluating a person’s candidacy for membership on the PubCo Board. The corporate governance and nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The corporate governance and nominating committee does not distinguish among nominees recommended by stockholders and other persons.
Compensation Committee
The compensation committee of the PubCo Board consists of David Card, Shachar Kariv and Jaeyoung Shin, each of whom meets the definition of “independent director” under the Nasdaq rules. Shachar Kariv is the chairperson of the compensation committee. The compensation committee’s duties, which are specified in PubCo’s Compensation Committee Charter, include, but are not limited to:
| ● | reviewing and approving on an annual basis the corporate goals and objectives relevant to PubCo’s Chief Executive Officer’s compensation and evaluating PubCo’s Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration of PubCo’s Chief Executive Officer based on such evaluation; |
| ● | reviewing and making recommendations to the PubCo Board with respect to compensation and any incentive compensation and equity-based plans that are subject to board approval of all of PubCo’s other officers; |
| ● | reviewing PubCo’s executive compensation policies and plans; |
11
| ● | implementing and administering PubCo’s incentive compensation and equity-based remuneration plans; |
| ● | assisting PubCo’s management in complying with PubCo’s proxy statement and annual report disclosure requirements; |
| ● | reviewing and approving all special perquisites, special cash payments and other special compensation and benefit arrangements for PubCo’s officers and employees; |
| ● | producing a report on executive compensation to be included in PubCo’s annual proxy statement; and |
| ● | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser and the compensation committee is directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee is required to consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Code of Ethics
PubCo has adopted a written code of ethics that applies to its directors, officers and employees, including its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is posted on PubCo’s website at https://www.exascalelabs.ai. In addition, PubCo intends to post on its website all disclosures that are required by law or the Nasdaq rules concerning any amendments to, or waivers from, any provision of the code. The information on PubCo’s website is not incorporated by reference in this Current Report on Form 8-K, and is provided as an inactive textual reference only.
Executive Compensation
Information with respect to the historical compensation of PubCo’s executive officers is included in the Proxy Statement/Prospectus in the section titled “Compensation of Named Executive Officers and Directors of Exascale” beginning on page 263 of the Proxy Statement/Prospectus, which is incorporated herein by reference.
Going forward, decisions with respect to the compensation of PubCo’s executive officers, including its named executive officers, will be made by the compensation committee of the PubCo Board. PubCo anticipates that compensation for its executive officers will have the following components: base salary, cash bonus opportunities, equity compensation, employee benefits and severance protections.
Certain Relationships and Related Transactions
Certain relationships and related party transactions are described in the Proxy Statement/Prospectus in the section titled “Certain Relationships and Related Party Transactions” beginning on page 268 of the Proxy Statement/Prospectus, which is incorporated herein by reference.
12
Legal Proceedings
From time to time, PubCo and its subsidiaries may become involved in legal proceedings arising in the ordinary course of its business. PubCo is not currently a party to or aware of any proceedings that PubCo believes will have, individually or in the aggregate, a material adverse effect on PubCo’s business, financial condition or results of operations. Regardless of outcome, litigation can have an adverse impact on PubCo because of defense and settlement costs, diversion of management resources and other factors.
Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters
Market Information and Holders
Immediately prior to the closing of the Business Combination, the BCAR Units, the BCAR Class A Ordinary Shares and the BCAR Warrants were listed on Nasdaq under the symbols “BCARU,” “BCAR” and “BCARW,” respectively.
In connection with the Business Combination, as of the Closing Date, all of the BCAR Units separated into their component parts and ceased trading on Nasdaq.
On August 28, 2026, the PubCo Class A Ordinary Common Stock and PubCo Warrants began trading on Nasdaq under the symbols “XLAB” and XLABW,” respectively. The PubCo Class B Super Common Stock are not listed on Nasdaq or any other securities exchange and are not publicly traded.
As of the Closing Date and following the completion of the Business Combination, PubCo had approximately 33,689,050 shares of PubCo Class A Ordinary Common Stock issued and outstanding held of record by 37 holders and 30,645,739 shares of PubCo Class B Super Common Stock issued and outstanding held of record by five holders.
Dividends
PubCo has not paid any cash dividends on the PubCo Common Stock to date, and currently does not anticipate declaring any cash dividends on the PubCo Common Stock in the foreseeable future. Any decision to declare and pay cash dividends on the PubCo Common Stock in the future will be made at the discretion of the PubCo Board and will depend on, among other things, PubCo’s revenues and earnings, if any, capital requirements, contractual restrictions, general financial condition and other factors the PubCo Board may deem relevant.
Recent Sales of Unregistered Securities
Information about recent sales of unregistered securities is set forth in the Proxy Statement/Prospectus in the section titled “Information about Exascale—Recent Sales of Unregistered Securities” on page 230 of the Proxy Statement/Prospectus, which is incorporated herein by reference.
Description of Registrant’s Securities
The description of PubCo’s securities is set forth in the section of the Proxy Statement/Prospectus entitled “Description of PubCo’s Securities” beginning on page 304 of the Proxy Statement/Prospectus, which information is incorporated herein by reference.
13
Indemnification of Directors and Officers
In connection with the Business Combination, on the Closing Date, PubCo entered into the Indemnification Agreements with each of its directors and executive officers. Subject to certain exceptions, the Indemnification Agreements provide that PubCo will indemnify each of its directors and executive officers for certain expenses, which may include attorneys’ fees, judgments, fines and settlement amounts, incurred by a director or officer in any action or proceeding arising out of that person’s services as a director or officer of PubCo or of any other company or enterprise to which the person provides services at PubCo’s request.
The foregoing description of the Indemnification Agreements is qualified in its entirety by reference to the form of Indemnification Agreement, a copy of which is attached as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Supplementary Data
The information set forth under Item 9.01 of this Current Report on Form 8-K is incorporated herein by reference.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
The information set forth in Item 4.01 of this Current Report on Form 8-K is incorporated herein by reference.
Financial Statements and Exhibits
The information set forth in Item 9.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
Prior to the consummation of the Business Combination, the BCAR Units, the BCAR Class A Ordinary Shares and the BCAR Warrants were listed on Nasdaq under the symbols “BCARU,” “BCAR” and “BCARW,” respectively. On the Closing Date, all of the issued and outstanding BCAR Units separated into their component securities and the BCAR Units, the BCAR Class A Common Stock and BCAR Rights ceased trading on Nasdaq.
In connection with the Business Combination, the PubCo Class A Ordinary Common Stock and PubCo Warrants were approved for listing on Nasdaq. The PubCo Class A Ordinary Common Stock and the PubCo Warrants began trading on Nasdaq under the symbols “XLAB” and “XLABW,” respectively, on August 28, 2026.
Item 3.03 Material Modification to Rights of Security Holders.
The material terms of the organizational documents of PubCo and the general effect upon the rights of holders of PubCo’s capital stock are described in the sections of the Proxy Statement/Prospectus entitled “The Organizational Documents Proposal” beginning on page 150 of the Proxy Statement/Prospectus, “The Advisory Organizational Documents Proposals” beginning on page 152 of the proxy statement/prospectus and “Description of PubCo’s Securities” beginning on page 304 of the Proxy Statement/Prospectus, which information is incorporated herein by reference.
On the Closing Date, PubCo filed an Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware and adopted new Bylaws in connection with the Business Combination. Copies of the Amended and Restated Certificate of Incorporation and Bylaws are filed as Exhibits 3.1 and 3.2 to this Current Report on Form 8-K, respectively, and are incorporated herein by reference.
14
Item 4.01 Changes in Registrant’s Certifying Accountant.
Upon the consummation of the Business Combination, PubCo appointed HTL International, LLC as its independent registered public accounting firm to audit PubCo’s consolidated financial statements as of and for the year ending June 30, 2027, effective immediately.
Accordingly, Guangdong Prouden CPAs GP (“Guangdong Prouden”), the independent registered public accounting firm for BCAR prior to the Business Combination, was dismissed as of the date of the consummation of the Business Combination.
Guangdong Prouden’s report on BCAR’s financial statements as of December 31, 2025 and for the period from March 20, 2025 (inception) through December 31, 2025 contained an explanatory paragraph relating to going concern, but otherwise did not contain any adverse opinion or disclaimer of opinion, nor was it qualified or modified as to uncertainty, audit scope or accounting principles.
There were no “disagreements” (as such term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with Guangdong Prouden on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Guangdong Prouden, would have caused Guangdong Prouden to make reference thereto in its report on BCAR’s financial statements for such periods. There have been no “reportable events” (as such term is defined in Item 304(a)(1)(v) of Regulation S-K).
PubCo provided Guangdong Prouden with a copy of the foregoing disclosures and has requested that Guangdong Prouden furnish PubCo with a letter addressed to the SEC stating whether it agrees with the statements made by PubCo set forth above. A copy of Guangdong Prouden’s letter, dated September 2, 2026, is filed as Exhibit 16.1 to this Current Report on Form 8-K.
Item 5.01 Changes in Control of Registrant.
The information set forth in the Introductory Note of this Current Report on Form 8-K and in the section entitled “Security Ownership of Certain Beneficial Owners and Management” in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
The information set forth in the Introductory Note of this Current Report on Form 8-K and in the section entitled “Information about Directors and Executive Officers” in Item 2.01 of this Current Report on Form 8-K is incorporated by reference herein.
Equity Incentive Plan
In connection with the Business Combination, PubCo adopted the Exascale Labs Holdings Inc. 2026 Omnibus Incentive Plan (the “Equity Incentive Plan”). The Equity Incentive Plan initially reserves 10,000,000 shares of PubCo Class A Ordinary Common Stock for issuance of awards under the Equity Incentive Plan. The Equity Incentive Plan provides that the number of shares reserved and available for issuance under the Equity Incentive Plan will automatically increase each January 1, beginning on January 1, 2027, by five percent of the outstanding number of shares of PubCo Class A Ordinary Common Stock on the immediately preceding December 31, or such lesser amount as determined by the PubCo Board in its discretion. The material terms of the Equity Incentive Plan are discussed in the section of the Proxy Statement/Prospectus entitled “The Equity Incentive Plan Proposal” beginning on page 160 of the Proxy Statement/Prospectus, which information is incorporated herein by reference.
15
Directors and Executive Officers
The information regarding PubCo’s directors and executive officers set forth under the headings “Information about Directors and Executive Officers” and “Executive Compensation” in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
The information set forth in Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference. In connection with the consummation of the Business Combination, PubCo changed its fiscal year end from December 31 to June 30, which is the fiscal year end historically used by Exascale.
Item 5.06 Change in Shell Company Status.
As a result of the Business Combination, which fulfilled the definition of a business combination as required by BCAR’s organizational documents, BCAR ceased to be a shell company (as defined in Rule 12b-2 of the Exchange Act) as of the Closing Date. The material terms of the Business Combination are described in the Proxy Statement/Prospectus in the section entitled “The Business Combination Proposal” beginning on page 120 of the Proxy Statement/Prospectus which is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
On August 27, 2026, PubCo issued a press release announcing the consummation of the Business Combination, which is included in this Current Report on Form 8-K as Exhibit 99.2.
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired
The following historical audited financial statements and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus:
| ● | Audited consolidated financial statements of BCAR as of December 31, 2025 and for the period from March 20, 2025 (inception) through December 31, 2025, audited by Guangdong Prouden CPAs GP. |
| ● | Audited financial statements of Exascale as of and for the years ended June 30, 2025 and 2024, audited by HTL International, LLC. |
The historical audited financial statements of BCAR and the related notes are included in the Proxy Statement/Prospectus beginning on page F-20 of the Proxy Statement/Prospectus, and the historical audited financial statements of Exascale and the related notes are included in the Proxy Statement/Prospectus beginning on page F-61 of the Proxy Statement/Prospectus.
The unaudited interim consolidated financial statements of Exascale as of and for the three and nine months ended March 31, 2026 and March 31, 2025, are included in the Proxy Statement/Prospectus beginning on page F-87 of the Proxy Statement/Prospectus and are incorporated by reference herein.
The unaudited interim consolidated financial statements of BCAR as of and for the three months ended March 31, 2026, and as of and for the period from March 20, 2025 (inception) through March 31, 2025, are included in the Proxy Statement/Prospectus beginning on page F-42 of the Proxy Statement/Prospectus and are incorporated by reference herein.
17
(b) Pro Forma Financial Information
The unaudited pro forma condensed combined financial information of BCAR and Exascale as of March 31, 2026, for the nine months ended March 31, 2026, and for the year ended June 30, 2025 is set forth in Exhibit 99.1 hereto and incorporated by reference herein
(d) Exhibits
Exhibit Index
| Exhibit No. | Description | |
| 2.1+ | Business Combination Agreement, dated January 11, 2026, by and among D. Boral ARC Acquisition I Corp., D. Boral ARC Merger Corporation, D. Boral Arc Merger Sub Inc. and Exascale Labs Inc. (incorporated by reference to Annex A to the proxy statement/prospectus forming a part of the Registration Statement on Form S-4 filed with the SEC on July 1, 2026) | |
| 3.1 | Amended and Restated Certificate of Incorporation | |
| 3.2 | Bylaws of Exascale Labs Holdings Inc. | |
| 10.1 | Form of Exascale Stockholder Lock-Up Agreement | |
| 10.2 | Form of Exascale SAFEholder Acknowledgement and Lock-Up Agreement | |
| 10.3 | Form of Indemnification Agreement | |
| 10.4 | Exascale Labs Holdings Inc. 2026 Omnibus Equity Incentive Plan | |
| 16.1 | Letter from Guangdong Prouden CPAs GP to the Securities and Exchange Commission, dated September 2, 2026. | |
| 99.1 | Unaudited pro forma condensed combined financial information of BCAR and Exascale as of March 31, 2026, for the nine months ended March 31, 2026, and for the year ended June 30, 2025. | |
| 99.2 | Press Release announcing consummation of the Business Combination. | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| + | Schedule and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). PubCo agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. |
18
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: September 2, 2026 | EXASCALE LABS HOLDINGS INC. | |
| By: | /s/ Hoansoo Lee | |
| Name: | Hoansoo Lee | |
| Title: | Chief Executive Officer | |
19
Exhibit 99.1
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Introduction
Capitalized terms used and not defined in this Exhibit shall have the meanings assigned to them in the Current Report on Form 8-K to which this Exhibit is attached.
As previously disclosed, On January 11, 2026, BCAR, Exascale, PubCo and Merger Sub entered into the Business Combination Agreement. The Business Combination closed on August 27, 2026.
BCAR is a blank check company incorporated in the British Virgin Islands on March 20, 2025. BCAR was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
On August 1, 2025, BCAR consummated its initial public offering of 28,000,000 public units at $10.00 per unit, which included 3,000,000 units issued upon the underwriters’ partial exercise of their over-allotment option, generating gross proceeds of $280,000,000. Simultaneously, BCAR completed the private placement of 200,000 units to the Sponsor at $10.00 per unit, generating additional proceeds of $2,000,000. Total transaction costs amounted to $3,582,634, which included a non-cash expense of $2,419,400 representing the fair value of 1,000,000 Class A ordinary shares issued to the representative of the underwriters, and $1,163,234 of other cash offering costs.
D. Boral ARC Merger Corporation (“PubCo”) is a Delaware company formed by D. Boral ARC Acquisition I Corp. (“BCAR”) on December 19, 2025 (inception). PubCo was formed to be the surviving company in connection with a contemplated business combination between BCAR and a target company. PubCo has no principal operations or revenue producing activities.
Exascale Labs Inc. (“Exascale”) is a next-generation AI infrastructure provider operating an asset-light, software-defined GPU compute platform and related AI infrastructure solutions. Exascale’s core business includes GPU as a Service (“GaaS”), through which it provides reserved and on-demand access to high-performance GPU compute capacity sourced from third-party data centers globally, as well as GPU cluster management and optimization services for AIDC operators. In addition, Exascale has developed certain modular data center, high-density liquid cooling, HVDC power and energy storage solutions that are designed to address deployment bottlenecks in AI infrastructure and that Exascale believes are ready for commercial engagement, although these capabilities have not yet generated revenue as of the date of the Current Report on Form 8-K to which this Exhibit is attached.
Upon the closing of the Business Combination, D. Boral ARC Merger Corporation was renamed as “Exascale Labs Holdings Inc.” Exascale Labs Holdings Inc. is providing the following unaudited pro forma condensed combined financial information to aid in the analysis of the financial aspects of the Business Combination and other events contemplated by the Business Combination Agreement. The following unaudited pro forma condensed combined financial information presents the combination of the financial information of BCAR and Exascale, adjusted to give effect to the Business Combination and other events contemplated by the Business Combination Agreement.
The unaudited pro forma condensed combined balance sheet as of March 31, 2026 combines the historical balance sheet of BCAR as of March 31, 2026 with the historical balance sheet of Exascale as of March 31, 2026 on a pro forma basis as if the Business Combination had been consummated on March 31, 2026. This presentation has been prepared in accordance with Article 11 of Regulation S-X to facilitate understanding of the financial impacts.
The unaudited pro forma condensed combined statement of operations for the nine months ended March 31, 2026 combines the historical statement of operations of BCAR for the nine months ended March 31, 2026 and the historical statement of operations of Exascale for the nine months ended March 31, 2026 on a pro forma basis as if the Business Combination had been consummated on July 1, 2024. The unaudited pro forma condensed combined statement of operations for the year ended June 30, 2025 combines the historical statement of operations of BCAR for the period from March 20, 2025 (inception) through June 30, 2025 and the historical statement of operations of Exascale for the year ended June 30, 2025 on a pro forma basis as if the Business Combination had been consummated on July 1, 2024.
The unaudited pro forma condensed combined financial information was derived from and should be read in conjunction with the following historical financial statements and the accompanying notes, which are incorporated by reference in the Current Report on Form 8-K to which this Exhibit is attached:
| ● | the historical unaudited financial statements of BCAR as of and for the period from March 20, 2025 (inception) through June 30, 2025, the historical audited financial statements of BCAR as of and for the period from March 20, 2025 (inception) through December 31, 2025 and the historical unaudited financial statements of BCAR as of and for the three months ended March 31, 2026; |
| ● | the historical audited financial statements of Exascale as of and for the year ended June 30, 2025 and the historical unaudited financial statements of Exascale as of and for the three and nine months ended March 31, 2026; and |
| ● | other information relating to Exascale and BCAR, including the Business Combination Agreement and the description of certain terms thereof and the financial and operational condition of BCAR and Exascale. |
The unaudited pro forma condensed combined financial statements have been presented for illustrative purposes only and do not necessarily reflect what Exascale’s financial condition or results of operations would have been had the Business Combination been consummated on the dates indicated. The unaudited pro forma condensed combined financial information also may not be useful in predicting the future financial condition and results of operations of the post-combination company. The unaudited pro forma condensed combined financial statements include certain assumptions, which may ultimately not come to fruition. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. The unaudited pro forma adjustments and the assumptions included in these unaudited pro forma condensed combined financial statements represent management’s estimates based on information available as of the date of these unaudited pro forma condensed combined financial statements and are subject to change as additional information becomes available and analyses are performed. In addition, the unaudited pro forma condensed combined financial statements do not purport to project the future financial position or operating results of the post-Closing company.
Description of the Transactions
On January 11, 2026, BCAR, Exascale, PubCo and Merger Sub entered into the Business Combination Agreement. Pursuant to the Business Combination Agreement, the Business Combination was effected in two steps: (i) a merger of BCAR with and into PubCo for the purpose of redomiciling BCAR from the British Virgin Islands to the State of Delaware (the “Domestication Merger”), with PubCo continuing as the surviving corporation and, upon effectiveness of the Domestication Merger, changing its name to “Exascale Labs Holdings Inc.”; and (ii) immediately thereafter, a merger of Merger Sub with and into Exascale, with Exascale surviving as a wholly owned subsidiary of PubCo (the “Acquisition Merger” and, together with the Domestication Merger, the “Business Combination”).
On August 27, 2026 (the “Closing Date”), the parties consummated the Business Combination, following approval by BCAR’s shareholders at an extraordinary general meeting held on July 29, 2026. In the Domestication Merger, BCAR continued out of the British Virgin Islands and into the State of Delaware pursuant to the Business Companies Act (Revised Edition 2020), as amended, of the British Virgin Islands and Section 388 and other applicable provisions of the General Corporation Law of the State of Delaware, with PubCo surviving as a Delaware corporation under the name “Exascale Labs Holdings Inc.” At the effective time of the Domestication Merger, (i) 1,200,000 issued and outstanding BCAR Class A ordinary shares and 12,000,000 BCAR Class B ordinary shares, together with 1,134,789 BCAR Class A ordinary shares that remained issued and outstanding and were not redeemed in connection with the shareholder vote (in each case, other than shares held as treasury shares, shares held by subsidiaries of BCAR, shares held by BCAR shareholders who properly exercised dissenter’s rights under applicable law, and BCAR Class A ordinary shares that were redeemed in connection with the shareholder vote) were cancelled and converted into 14,334,789 shares of Class A common stock, par value $0.0001 per share, of PubCo (“PubCo Class A Ordinary Common Stock”), and (ii) each warrant of BCAR outstanding immediately prior to the Domestication Merger (each, a “BCAR Warrant”) was assumed by PubCo and became a warrant of PubCo (each, a “PubCo Warrant”), exercisable for PubCo Class A Ordinary Common Stock on the same terms as were applicable to the BCAR Warrants, subject to adjustments contemplated by the Business Combination Agreement.
2
In connection with the extraordinary general meeting and the Business Combination, holders of 26,865,211 BCAR Class A ordinary shares exercised their redemption rights and redeemed their shares for cash. On the Closing Date, there were 1,134,789 shares of PubCo Class A Ordinary Common Stock outstanding that were held by former BCAR public shareholders.
Following the Domestication Merger, Merger Sub merged with and into Exascale, with Exascale surviving as a wholly owned subsidiary of PubCo. At the closing of the Acquisition Merger, the aggregate consideration payable to Exascale and its securityholders (the “Merger Consideration”) was $500,000,000, payable in the form of 50,000,000 newly issued shares of common stock of PubCo, valued at $10.00 per share. The Merger Consideration was allocated among Exascale’s various securityholder groups based on their respective “implied ownership percentages,” determined by reference to Exascale’s fully diluted capitalization and the specific contractual terms applicable to each category of security. In particular:
(i) each Simple Agreement for Future Equity (“SAFE”) between Exascale and a SAFE holder was cancelled and converted into the right to receive a number of shares of PubCo Class A Ordinary Common Stock based on the SAFE’s implied ownership percentage (which, in general, was equal to the product of (x) the quotient obtained by dividing the SAFE’s purchase amount by its post-money valuation cap and (y) 100, subject to capitalization and rounding adjustments), with all outstanding SAFEs as of the proxy statement/prospectus filing date collectively entitled to receive 8,864,761 shares of PubCo Class A Ordinary Common Stock, representing an aggregate implied ownership percentage of 17.730%;
(ii) that certain Base Camp Investment Agreement, dated May 9, 2023 (the “Base Camp Investment Agreement”), was cancelled and converted into the right to receive 312,500 shares of PubCo Class A Ordinary Common Stock, representing an implied ownership percentage of 0.625%;
(iii) each outstanding Exascale equity incentive award was cancelled and converted into the right to receive PubCo Class A Ordinary Common Stock based on the implied ownership percentage attributable to such award, which, based on Exascale’s capitalization as of the proxy statement/prospectus filing date, was 0.154%, entitling such award holders to receive an aggregate of 77,000 shares of PubCo Class A Ordinary Common Stock;
(iv) each issued and outstanding share of Exascale Class A common stock was cancelled and converted into the right to receive PubCo Class A Ordinary Common Stock based on the implied ownership percentage attributable to Exascale’s Class A common stock, which, based on the same capitalization date, was 20.200%, entitling the holders of Exascale Class A common stock to receive an aggregate of 10,100,000 shares of PubCo Class A Ordinary Common Stock; and
(v) each issued and outstanding share of Exascale Class B common stock was cancelled and converted into the right to receive PubCo Class B common stock, par value $0.0001 per share (“PubCo Class B Super Common Stock”), based on the implied ownership percentage attributable to Exascale’s Class B common stock, which, based on the same capitalization date, was 61.291%, entitling the holders of Exascale Class B common stock to receive an aggregate of 30,645,739 shares of PubCo Class B Super Common Stock.
Each share of PubCo Class A Ordinary Common Stock carries one vote per share, and each share of PubCo Class B Super Common Stock carries twenty votes per share. No fractional shares of PubCo Common Stock were issued in connection with the Business Combination. On the Closing Date, there were 19,354,261 shares of PubCo Class A Ordinary Common Stock and 30,645,739 shares of PubCo Class B Super Common Stock outstanding that were held by former Exascale securityholders.
3
As of the Closing Date and upon completion of the Business Combination, PubCo had approximately 64,334,789 shares of PubCo Common Stock issued and outstanding, consisting of approximately 33,689,050 shares of PubCo Class A Ordinary Common Stock and 30,645,739 shares of PubCo Class B Super Common Stock, and no shares of preferred stock outstanding. In addition, as of the Closing Date, PubCo had 14,099,992 PubCo Warrants outstanding, each whole PubCo Warrant entitling the holder to purchase one share of PubCo Class A Ordinary Common Stock at an exercise price of $11.50 per share.
The pro forma combined financial information takes into account the actual redemptions of BCAR Ordinary Shares that occurred as of the Closing Date of the Business Combination.
The pro forma shares of the combined common stock issued and outstanding immediately after the Business Combination are as below:
| Actual Redemption | ||||
| Common Stock | ||||
| PubCo Class A Ordinary Common Stock held by BCAR stockholders(1) | 1,134,789 | |||
| PubCo Class A Ordinary Common Stock held by BCAR sponsor and affiliates(2) | 12,200,000 | |||
| PubCo Class A Ordinary Common Stock held by underwriter(3) | 1,000,000 | |||
| PubCo Class A Ordinary Common Stock held by Exascale SAFEholders(4) | 8,864,761 | |||
| PubCo Class A Ordinary Common Stock held by Base Camp Investment Agreement Investor(5) | 312,500 | |||
| PubCo Class A Ordinary Common Stock held by Exascale Equity Incentive Recipients(6) | 77,000 | |||
| PubCo Class A Ordinary Common Stock held by Exascale Class A common stockholders(7) | 10,100,000 | |||
| PubCo Class B Super Common Stock held by Exascale Class B common stockholders(8) | 30,645,739 | |||
| Total | 64,334,789 | |||
| 1. | Consists of 1,134,789 shares of PubCo Class A Ordinary Common Stock, resulting from the conversion by BCAR’s public stockholders on a one-for-one basis. |
| 2. | Consists of (i) 200,000 shares of PubCo Class A Ordinary Common Stock converted from private units held by the Sponsor, and (ii) 12,000,000 shares of PubCo Class A Ordinary Common Stock converted from founder shares held by the Sponsor. |
| 3. | Consists of 1,000,000 shares of PubCo Class A Ordinary Common Stock converted from representative shares held by the underwriter in BCAR’s initial public offering. |
| 4. | Consists of 8,864,761 shares of PubCo Class A Ordinary Common Stock converted from Exascale SAFEholders. |
| 5. | Consists of 312,500 shares of PubCo Class A Ordinary Common Stock converted from Base Camp Investment Agreement Investor. |
| 6. | Consists of 77,000 shares of PubCo Class A Ordinary Common Stock converted from Exascale Equity Incentive Recipients. |
| 7. | Consists of 10,100,000 shares of PubCo Class A Ordinary Common Stock converted from Exascale Class A common stockholders. |
| 8. | Consists of 30,645,739 shares of PubCo Class A Ordinary Common Stock converted from Exascale Class B common stockholders. |
4
Accounting Treatment of the Business Combination
The Business Combination was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, while BCAR was the legal acquirer, it was treated as the acquired company for financial reporting purposes. Accordingly, the financial statements of Exascale represented a continuation of the financial statements of Exascale, with the Business Combination treated as the equivalent of Exascale issuing stock for the net assets of BCAR, accompanied by a recapitalization. The net assets of BCAR were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination will be presented as those of Exascale in future reports of Exascale Labs Holdings Inc.
Exascale has been determined to be the accounting acquirer based on the evaluation of the following facts and circumstances:
| ● | Exascale stockholders had a significant majority of the voting power of PubCo; |
| ● | PubCo’s board of directors consisted of five members, all of whom were designated by Exascale; |
| ● | Exascale’s senior management comprised the senior management of PubCo and were responsible for the day-to-day operations of PubCo; |
| ● | Exascale is the larger entity based on historical operating activity and employee base; and |
| ● | Exascale’s operations comprise the ongoing operations of PubCo. |
Exascale has been designated as the accounting acquirer and has a fiscal year end of June 30. Upon the Closing, the surviving public entity continues to have June 30 as its fiscal year end.
Basis of Pro Forma Presentation
The historical financial information has been adjusted to give pro forma effect to events that are related and/or directly attributable to the Business Combination, are factually supportable, and as it relates to the unaudited pro forma combined statement of operations, are expected to have a continuing impact on the results of the post-combination company. The adjustments presented on the unaudited pro forma combined financial statements have been identified and presented to provide relevant information necessary for an accurate understanding of the post-combination company upon consummation of the Business Combination.
The unaudited pro forma combined financial information is for illustrative purposes only. The financial results may have been different had the companies always been combined. You should not rely on the unaudited pro forma combined financial information as being indicative of the historical financial position and results that would have been achieved had the companies always been combined or the future financial position and results that the post-combination company will experience. Exascale and BCAR have not had any historical relationship prior to the Business Combination. Accordingly, no pro forma adjustments were required to eliminate activities between the companies.
The pro forma adjustments included in the unaudited pro forma condensed combined balance sheet as of March 31, 2026, and in the unaudited pro forma condensed combined statement of operations for the year ended June 30, 2025 and for the nine months ended March 31, 2026 are based on the actual values as of the Closing Date. The differences that may occur between the presented value and the final purchase accounting could have a material impact on the accompanying unaudited pro forma condensed combined financial information.
5
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
As of March 31, 2026
| Actual Redemptions | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exascale Labs Inc. | BCAR | Transaction Accounting Adjustments |
Pro Forma Combined |
|||||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||||
| $ | $ | $ | $ | |||||||||||||||
| ASSETS | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | 984,830 | 243,576 | 287,319,687 | A | 12,936,198 | |||||||||||||
| (270,030 | ) | B1 | ||||||||||||||||
| (666,722 | ) | B2 | ||||||||||||||||
| (275,675,143 | ) | C | ||||||||||||||||
| 1,000,000 | E1 | |||||||||||||||||
| U.S. Dollar Coin | 4,074,415 | - | 4,074,415 | |||||||||||||||
| Accounts receivable, net | 1,830,105 | - | 1,830,105 | |||||||||||||||
| Prepaid research and development expenses | 625,000 | - | 625,000 | |||||||||||||||
| Advance to suppliers | 106,801 | - | 106,801 | |||||||||||||||
| Refundable deposits receivable | 510,000 | - | 510,000 | |||||||||||||||
| Prepayment and other receivable | - | 156,259 | 156,259 | |||||||||||||||
| Total Current Assets | 8,131,151 | 399,835 | 11,707,792 | 20,238,778 | ||||||||||||||
| Non-current assets: | ||||||||||||||||||
| Cash and securities held in Trust Account | - | 287,319,687 | (287,319,687 | ) | A | - | ||||||||||||
| Property, equipment and software, net | 14,406 | - | 14,406 | |||||||||||||||
| Deferred Offering Cost | 95,000 | - | (95,000 | ) | B1 | - | ||||||||||||
| Total Non-current Assets | 109,406 | 287,319,687 | (287,414,687 | ) | 14,406 | |||||||||||||
| TOTAL ASSETS | 8,240,557 | 287,719,522 | (275,706,895 | ) | 20,253,184 | |||||||||||||
| LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||
| Accounts payable | 743,742 | - | 743,742 | |||||||||||||||
| Simple agreement for future equity | 26,842,205 | - | - | |||||||||||||||
| - | 1,000,000 | E1 | ||||||||||||||||
| - | (27,842,205 | ) | E2 | |||||||||||||||
| Contract liabilities | 109,657 | 109,657 | ||||||||||||||||
| Refundable deposits payable | 1,174,702 | 1,174,702 | ||||||||||||||||
| Accrued expense and other current liabilities | 283,612 | 345,713 | 400,000 | B2 | 979,325 | |||||||||||||
| (50,000 | ) | D | ||||||||||||||||
| Total Current Liabilities | 29,153,918 | 345,713 | (26,492,205 | ) | 3,007,426 | |||||||||||||
| Total Liabilities | 29,153,918 | 345,713 | (26,492,205 | ) | 3,007,426 | |||||||||||||
| COMMITMENTS AND CONTINGENCIES | ||||||||||||||||||
| Temporary equity: | ||||||||||||||||||
| Common stock subject to possible redemption | - | 287,319,687 | (287,319,687 | ) | C | - | ||||||||||||
| Stockholders’ Equity (Deficit) | ||||||||||||||||||
| Class A common shares | 3 | 120 | 113 | C | 3,368 | |||||||||||||
| 31 | D | |||||||||||||||||
| 886 | E2 | |||||||||||||||||
| 1,200 | F | |||||||||||||||||
| 1,018 | G | |||||||||||||||||
| (3 | ) | G | ||||||||||||||||
| Class B common shares | 12 | 1,200 | (1,200 | ) | F | 3,065 | ||||||||||||
| 3,065 | G | |||||||||||||||||
| (12 | ) | G | ||||||||||||||||
| Additional paid-in capital | 220,636 | (233,600 | ) | B1 | 39,440,059 | |||||||||||||
| 11,644,431 | C | |||||||||||||||||
| 49,969 | D | |||||||||||||||||
| 27,841,319 | E2 | |||||||||||||||||
| (82,696 | ) | G | ||||||||||||||||
| Accumulated deficit | (21,134,012 | ) | 52,802 | (131,430 | ) | B1 | (22,200,734 | ) | ||||||||||
| (1,066,722 | ) | B2 | ||||||||||||||||
| 78,628 | G | |||||||||||||||||
| Other Comprehensive Income (Loss) | - | - | ||||||||||||||||
| Total Stockholders’ Equity (Deficit) | (20,913,361 | ) | 54,122 | 38,104,997 | 17,245,758 | |||||||||||||
| TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT) | 8,240,557 | 287,719,522 | (275,706,895 | ) | 20,253,184 | |||||||||||||
See accompanying notes to the unaudited pro forma condensed combined financial statements.
6
Unaudited Pro Forma Condensed Combined Statement of Operations
For the nine months ended March 31, 2026
| For the nine months ended March 31, |
Actual Redemptions | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | Pro Forma | Pro Forma | ||||||||||||||||
| Exascale | BCAR | Adjustments | Combined | |||||||||||||||
| $ | $ | $ | $ | |||||||||||||||
| Revenue | 10,561,331 | 10,561,331 | ||||||||||||||||
| Cost of revenues | (8,902,966 | ) | (8,902,966 | ) | ||||||||||||||
| Operating costs and expenses: | ||||||||||||||||||
| Selling and marketing expenses | (310,582 | ) | - | (310,582 | ) | |||||||||||||
| General and administrative expenses | (928,255 | ) | - | (928,255 | ) | |||||||||||||
| Research and development expenses | (3,238,185 | ) | - | (3,238,185 | ) | |||||||||||||
| Formation and operational costs | - | (810,979 | ) | 160,000 | I | (650,979 | ) | |||||||||||
| Total operating expenses | (4,477,022 | ) | (810,979 | ) | 160,000 | (5,128,001 | ) | |||||||||||
| Income (loss) from operations | (2,818,657 | ) | (810,979 | ) | 160,000 | (3,469,636 | ) | |||||||||||
| Other income (expense): | ||||||||||||||||||
| Change in fair value of simple agreements for future equity | (5,098,320 | ) | - | 5,098,320 | H | - | ||||||||||||
| Unrealized loss on marketable securities held in Trust Account | - | 7,319,687 | (7,319,687 | ) | J | - | ||||||||||||
| Total other income (expense) | (5,098,320 | ) | 7,319,687 | (2,221,367 | ) | - | ||||||||||||
| Loss before income tax expense | (7,916,977 | ) | 6,508,708 | (2,061,367 | ) | (3,469,636 | ) | |||||||||||
| Income tax expense | - | - | - | - | ||||||||||||||
| Net (loss) income | (7,916,977 | ) | 6,508,708 | (2,061,367 | ) | (3,469,636 | ) | |||||||||||
| Basic and Diluted | - | |||||||||||||||||
| Loss per share | (0.054 | ) | ||||||||||||||||
7
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Year ended June 30, 2025
| For the year ended June 30, |
Actual Redemptions | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | Pro Forma | Pro Forma | ||||||||||||||||
| Exascale | BCAR | Adjustments | Combined | |||||||||||||||
| $ | $ | $ | $ | |||||||||||||||
| Revenue | 7,015,512 | 7,015,512 | ||||||||||||||||
| Cost of revenues | (5,910,315 | ) | (5,910,315 | ) | ||||||||||||||
| Operating costs and expenses: | ||||||||||||||||||
| Selling and marketing expenses | (989,155 | ) | (989,155 | ) | ||||||||||||||
| General and administrative expenses | (362,982 | ) | (1,066,722 | ) | B2 | (1,429,704 | ) | |||||||||||
| Research and development expenses | (2,797,906 | ) | (2,797,906 | ) | ||||||||||||||
| Formation and operational costs | - | (41,420 | ) | (41,420 | ) | |||||||||||||
| Total operating expenses | (4,150,043 | ) | (41,420 | ) | (1,066,722 | ) | (5,258,185 | ) | ||||||||||
| Loss from operations | (3,044,846 | ) | (41,420 | ) | (1,066,722 | ) | (4,152,988 | ) | ||||||||||
| Other income (expense): | ||||||||||||||||||
| Change in fair value of simple agreements for future equity | (4,614,821 | ) | - | 4,614,821 | H | - | ||||||||||||
| Total other income (expense) | (4,614,821 | ) | - | 4,614,821 | - | |||||||||||||
| Loss before income tax expense | (7,659,667 | ) | (41,420 | ) | 3,548,099 | (4,152,988 | ) | |||||||||||
| Income tax expense | - | - | - | - | ||||||||||||||
| Net (loss) income | (7,659,667 | ) | (41,420 | ) | 3,548,099 | (4,152,988 | ) | |||||||||||
| Basic and Diluted | ||||||||||||||||||
| Loss per share | (0.065 | ) | ||||||||||||||||
See accompanying notes to the unaudited pro forma condensed combined financial statements.
8
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
Note 1—Basis of the Pro Forma Presentation
The Business Combination was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, BCAR, who is the legal acquirer, is treated as the accounting acquiree for financial reporting purposes and Exascale, which is the legal acquiree, was treated as the accounting acquirer for financial reporting purposes.
The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X. Article 11 provides guidance to depict the accounting for the transaction (“Transaction Accounting Adjustments”) and present the reasonably estimable synergies and other transaction effects that have occurred or are reasonably expected to occur (“Management Adjustments”). Given such Management Adjustments, if any, would not enhance an understanding of the pro forma effects of the Transaction, BCAR has elected not to present any Management Adjustments and will only be presenting Transaction Accounting Adjustments in the following unaudited pro forma condensed combined financial information.
The pro forma adjustments reflecting the consummation of the Business Combination are based on certain currently available information and certain assumptions and methodologies that management believes are reasonable under the circumstances. The unaudited pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the difference may be material. Management believes that its assumptions and methodologies provide a reasonable basis for presenting all the significant effects of the Business Combination based on information available to management at this time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.
The unaudited pro forma condensed combined financial information does not include income tax effects as the parties to the Business Combination are evaluating the post-Closing tax implications of Exascale. Accordingly, the unaudited pro forma condensed combined provision for income taxes does not necessarily reflect the amounts that would have resulted had the parties to the Business Combination filed consolidated income tax returns during the periods presented, nor does it reflect the amounts of pro forma deferred tax assets or liabilities as of the periods presented.
The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination and related transactions taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of Exascale Labs Holdings Inc. They should be read in conjunction with the historical financial statements and notes thereto of BCAR and Exascale.
Note 2—Pro Forma Adjustments
BCAR and Exascale have not had any historical relationship prior to the Business Combination. Accordingly, no pro forma adjustments were required to eliminate activities between the companies.
Pro Forma Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet
The adjustments included in the unaudited pro forma condensed combined balance sheet as of March 31, 2026 are as follows:
| (A1) | Reflects the reclassification of cash and cash equivalents from the trust account that become available for use post-Closing. |
9
| (B1) | Reflects the settlement of total estimated professional fees incurred by Exascale not yet recognized in its historical financial statements. These costs are accounted for as equity issuance costs. |
| (B2) | Reflects the settlements and accruals of total estimated professional fees incurred by BCAR not yet recognized in its historical financial statements. These costs are accounted for as expenses. |
| (C) | Reflects the reclassification of common stock subject to possible redemption to permanent equity. |
| (D) | Reflects pro forma adjustments to record (i) $50,000 of cash proceeds received under the investor provider arrangement as other current liabilities, and (ii) share-based compensation expense for services that were fully provided, the total equity conversion to 312,500 common shares, with the related liability reclassified to common shares and additional paid-in capital. |
| (E1) | Reflects Exascale’s issuance in July 2026 of an aggregate of $1.0 million in SAFE investment. |
| (E2) | Reflects the conversion of Exascale SAFEs into an aggregate of 8,864,761 shares of Class A common stock. |
| (F) | Reflects the share exchanges for the recapitalization of BCAR. |
| (G) | Reflects the share exchanges for the recapitalization of Exascale including share-based compensation. |
Transaction Accounting Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations
The pro forma adjustments included in the unaudited pro forma condensed combined statements of operations for the nine months ended March 31, 2026 and for the year ended June 30, 2025 are as follows:
| (B2) | Reflects the settlement of total estimated professional fees incurred by BCAR not yet recognized in its historical financial statements. These costs are accounted for as expenses. |
| (H) | Reflects the elimination of remeasurement gains and losses on SAFEs. |
| (I) |
Reflects the elimination of monthly administration fee of $20,000 paid to the Sponsor after giving effect to the Business Combination as if it had occurred on July 1, 2024.
(BCAR entered into an administrative services agreement, commencing on August 1, 2025, through the earlier of BCAR’s consummation of an initial business combination or its liquidation, to pay to the Sponsor a total of $20,000 per month for office space, secretarial and administrative services provided to members of BCAR’s management team.) |
| (J) | Reflects the elimination of interest income generated from the investments held in the trust account after giving effect to the Business Combination as if it had occurred on July 1, 2024. |
10
Note 3—Loss per Share
As the Business Combination is being reflected as if it had been consummated on July 1, 2024, the calculation of weighted average shares outstanding for pro forma basic and diluted net loss per share assumes the following events occurred as of July 1, 2024:
| Actual Redemptions | ||||||||
| Year Ended June 30, 2025 |
Nine months Ended March 31, 2026 |
|||||||
| Pro forma net loss | $ | (4,152,988 | ) | $ | (3,469,636 | ) | ||
| Weighted average shares outstanding – basic | 64,334,789 | 64,334,789 | ||||||
| Weighted average shares outstanding – diluted | 64,334,789 | 64,334,789 | ||||||
| Net loss per share – basic | $ | (0.065 | ) | $ | (0.054 | ) | ||
| Net loss per share – diluted | $ | (0.065 | ) | $ | (0.054 | ) | ||
| Weighted average shares calculation, basic and diluted | ||||||||
| BCAR Public Shares | 1,134,789 | 1,134,789 | ||||||
| BCAR private placement shares held by Sponsor | 200,000 | 200,000 | ||||||
| BCAR Founder Shares held by Sponsor | 12,000,000 | 12,000,000 | ||||||
| Underwriter Representative shares | 1,000,000 | 1,000,000 | ||||||
| Post-Combination Company ordinary shares issued in the Business Combination to Exascale Securityholders | 50,000,000 | 50,000,000 | ||||||
| Weighted average shares outstanding, basic and diluted | 64,334,789 | 64,334,789 | ||||||
| Actual Redemptions | ||||||||
| Year Ended June 30, 2025 |
Nine months Ended March 31, 2026 |
|||||||
| BCAR public shares | 1.76 | % | 1.76 | % | ||||
| BCAR shares private placement shares held by Sponsor | 0.31 | % | 0.31 | % | ||||
| BCAR founder’s shares held by Sponsor | 18.65 | % | 18.65 | % | ||||
| Underwriter Represent shares | 1.55 | % | 1.55 | % | ||||
| Post-Combination Company ordinary shares issued in the Business Combination to Exascale Securityholders | 77.73 | % | 77.73 | % | ||||
| Total | 100.00 | % | 100.00 | % | ||||
11
Exhibit 99.2
Exascale Labs Holdings Inc. Announces Closing of Business
Combination with D. Boral ARC Acquisition I Corp. and
Commencement of Trading on Nasdaq under Ticker Symbol “XLAB”
| ● | Exascale to begin trading tomorrow, August 28, 2026, on Nasdaq under the symbol “XLAB” |
| ● | Next-generation AI infrastructure provider with scalable platform and approximately $300 million qualified customer pipeline to accelerate commercial deployment |
SAN FRANCISCO, Aug. 27, 2026 — Exascale Labs Inc., a provider of next-generation AI compute infrastructure, today announced the closing of its previously announced business combination with D. Boral ARC Acquisition I Corp. (Nasdaq: BCAR), a special purpose acquisition company (“BCAR”), following shareholder approval at the Extraordinary General Meeting of Shareholders of BCAR held on Wednesday, July 29, 2026.
The combined company has changed its name to Exascale Labs Holdings Inc. and its Class A common stock and warrants will begin trading on Nasdaq under the new symbols “XLAB” and “XLABW,” respectively, on August 28, 2026. Each existing BCAR unit will separate into its components consisting of one share of Class A common stock under the new symbol “XLAB” and one-half of one warrant under the new symbol “XLABW” and, as a result, the BCAR units will no longer trade as a separate security.
Exascale provides dedicated, scalable GPU compute and AI-ready data center solutions to a diversified customer base spanning enterprise AI developers, academic institutions, and AI-native platforms. AI infrastructure demand is increasingly constrained by the availability of deployable compute, power, cooling, and data center capacity. Exascale’s asset-light platform is designed to address these constraints by providing access to high-performance GPU capacity, GPU cluster management, and related infrastructure solutions for large-scale AI workloads, including training, fine-tuning, and inference.
“Completing this business combination and listing on Nasdaq opens a new chapter for Exascale,” said Hoansoo Lee, Chief Executive Officer of Exascale. “We are entering the public markets at a time when demand for AI compute is being shaped not only by GPU availability, but also by the ability to deploy reliable infrastructure at scale. As a public company, we remain focused on executing against our qualified customer pipeline, expanding our platform, and delivering high-performance AI compute infrastructure for enterprise, research, and AI-native customers.”
“Exascale combines a capital-efficient operating model with exposure to one of the most important infrastructure markets in technology,” said John Darwin, Chief Financial Officer of BCAR. “Exascale’s qualified customer pipeline, technical platform, and experienced management team give it a strong foundation as it enters the public markets. Thank you to Hoansoo and the Exascale team, our legal advisors, banking partners, and other strategic partners for their hard work throughout this process. We are proud to complete this transaction and to support Exascale as it begins its next chapter as a Nasdaq-listed company.”
About Exascale
Exascale is a next-generation AI infrastructure provider operating an asset-light, software-defined GPU compute platform and related AI infrastructure solutions. Exascale’s core business includes GPU-as-a-Service, through which it provides reserved and on-demand access to high-performance GPU compute capacity sourced from third-party data centers globally, as well as GPU cluster management and optimization services for AI data center operators.
In addition, Exascale has developed certain modular data center, high-density cooling, HVDC power and energy storage solutions designed to address deployment bottlenecks in AI infrastructure. Exascale’s platform is purpose-built for large-scale AI workloads, including LLM training, fine-tuning, and high-concurrency inference. For more information about Exascale, please visit: https://www.exascalelabs.ai.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “will,” and similar expressions. These statements include statements regarding the expected trading of the combined company’s securities on Nasdaq, the anticipated use of proceeds from the business combination, Exascale’s ability to execute against its qualified customer pipeline, expected demand for AI compute infrastructure, Exascale’s market positioning, business strategy, partnerships, growth, and future operating performance.
These statements are based on current expectations and assumptions, and involve risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements, including, among others, Exascale’s ability to realize the expected benefits of the business combination, successfully operate as a public company, access capital on acceptable terms, convert pipeline opportunities into revenue, manage supply constraints for GPUs and related infrastructure components, and execute its commercial strategy. In addition, Exascale’s customer pipeline consists of prospective customer opportunities and is not indicative of contracted revenue, bookings or backlog, and there can be no assurance that Exascale will convert any particular pipeline opportunity into a customer relationship or revenue, or that any such opportunity will be converted on the anticipated timing, terms or economics.
You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the definitive proxy statement and the final proxy statement/prospectus of BCAR, each dated as of July 6, 2026 and as further supplemented, and other documents that have been filed by BCAR with the SEC and other documents to be filed by Exascale from time to time with the SEC. These filings do or will identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. If any of these risks materialize or the assumptions prove incorrect, actual results could differ materially from the results contained in or implied by these forward-looking statements. There may be additional risks that Exascale does not presently know or cannot currently anticipate or that Exascale currently believes are immaterial that could also cause actual results to differ materially from those contained in or implied by the forward-looking statements.
In addition, forward-looking statements reflect Exascale’s expectations, plans or forecasts of future events and views as of the date of this press release. Exascale anticipates that subsequent events and developments will cause Exascale’s and assessments to change. However, while Exascale may elect to update these forward-looking statements at some point in the future, Exascale specifically disclaims any obligation to do so, except as required by applicable law. Readers are cautioned not to place undue reliance upon any forward-looking statements.
2
Investor Contact
Nick Hresko-Staab
KCSA Strategic Communications
Exascale@KCSA.com
Media Contact
Hannah Erger
KCSA Strategic Communications
Exascale@KCSA.com
3